Biotech · Private company · Norwood, MA, US
Veramorph, LLC
Track this companyFree. Adds Veramorph, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Preclinical validation of an effective oral fulvestrant product as the future standard of care endocrine therapy for ER+ metastatic breast cancerFiscal year 2026 · $935.2KNIH RePORTER 4R44CA306533-02 · fetched Nov 12, 2026
- Preclinical validation of an effective oral fulvestrant product as the future standard of care endocrine therapy for ER+ metastatic breast cancerFiscal year 2025 · $400KNIH RePORTER 1R44CA306533-01 · fetched Nov 12, 2026